Bupropion Hydrochloride
- Product NDC
- 50090-7335
- 11-digit product format
- 500907335
- Labeler code
- 50090
- Product ID
- 50090-7335_0e701a91-3362-4074-b22d-7a1d2274afc3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA207479
- Marketing category
- ANDA
- Marketing start
- 2017-04-12
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| ZG7E5POY8O | BUPROPION HYDROCHLORIDE | 31677-93-7 | BUPROPION HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7335-0 | 50090733500 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7335-0) | 2024-10-15 | No | No | Historical |